Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 3Withdrawn 2Recruiting 2

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Neoplasm Metastasis 25Leukemia, Myeloid, Acute 25Breast Neoplasms 18Prostatic Neoplasms 16Myelodysplastic Syndromes 15Lymphoma, Large B-Cell, Diffuse 15Leukemia, Lymphocytic, Chronic, B-Cell 15Multiple Myeloma 14Lung Neoplasms 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Colorectal Neoplasms 12Carcinoma, Non-Small-Cell Lung 12Triple Negative Breast Neoplasms 11Pancreatic Neoplasms 11Burkitt Lymphoma 11Neoplasms 9Lymphoma, Mantle-Cell 9Leukemia, Myelomonocytic, Chronic 9Ovarian Neoplasms 8Melanoma 8Stomach Neoplasms 7Lymphoma, T-Cell 7Squamous Cell Carcinoma of Head and Neck 6Lymphoma, B-Cell 6Carcinoma, Renal Cell 6Myeloproliferative Disorders 5Mouth Neoplasms 5Lymphoma 5Leukemia, Biphenotypic, Acute 5Fallopian Tube Neoplasms 5

Interventions

Tamoxifen 6Specimen Handling 6Anastrozole 3exemestane 2Surveys and Questionnaires 2Radiosurgery 2Letrozole 2Genetic Testing 2Biopsy 2poly ICLC 1elacestrant 1Testosterone 1Standard of Care 1Sentinel Lymph Node Biopsy 1Selective Estrogen Receptor Modulators 1Restraint, Physical 1Radiotherapy 1Practice Guidelines as Topic 1Patient Navigation 1Omacor 1Multicenter Studies as Topic 1Methods 1Meditation 1Medicare 1Mastectomy, Segmental 1Mastectomy 1Granulocyte-Macrophage Colony-Stimulating Factor 1Genetic Counseling 1Follow-Up Studies 1FAPI-46 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Carcinoma, Intraductal, Noninfiltrating × Biopsy × Clear all
NCT06184750 2026-05-13

Finding the Best Tamoxifen Dose for Breast Cancer Risk Reduction in Premenopausal Women, RENAISSANCE Trial

National Cancer Institute (NCI)

Phase 2 Recruiting
200 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating

NCT04144023 2026-03-05

A Vaccine (H2NVAC) Before Surgery for the Treatment of HER2-Expressing Ductal Carcinoma In Situ

Mayo Clinic

Phase 1 Recruiting
43 enrolled
Breast

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon âš¡